149 related articles for article (PubMed ID: 37916018)
1. Prevalence of P16 Immunohistochemistry Positive Staining and Its Correlation to Clinical and Radiological Staging of Squamous Cell Carcinoma of the Cervix.
El Sokkary HH; Sheta E
J Obstet Gynaecol India; 2023 Oct; 73(Suppl 1):142-149. PubMed ID: 37916018
[TBL] [Abstract][Full Text] [Related]
2. p16 Immunohistochemistry is useful in confirming high-grade squamous intraepithelial lesions (HSIL) in women with negative HPV testing.
Zhang G; Yang B; Abdul-Karim FW
Int J Gynecol Pathol; 2015 Mar; 34(2):180-6. PubMed ID: 25675189
[TBL] [Abstract][Full Text] [Related]
3. p16(INK4a) as a complementary marker of high-grade intraepithelial lesions of the uterine cervix. I: Experience with squamous lesions in 189 consecutive cervical biopsies.
Dray M; Russell P; Dalrymple C; Wallman N; Angus G; Leong A; Carter J; Cheerala B
Pathology; 2005 Apr; 37(2):112-24. PubMed ID: 16028838
[TBL] [Abstract][Full Text] [Related]
4. P16 immunostaining and HPV testing in histological specimens from the uterine cervix.
Capobianco G; Marras V; Wenger JM; Santeufemia DA; Ambrosini G; Lutzoni R; Dessole M; Cherchi PL
Eur J Gynaecol Oncol; 2013; 34(3):227-30. PubMed ID: 23967551
[TBL] [Abstract][Full Text] [Related]
5. p16 expression in squamous and trophoblastic lesions of the upper female genital tract.
Chew I; Post MD; Carinelli SG; Campbell S; Di Y; Soslow RA; Oliva E
Int J Gynecol Pathol; 2010 Nov; 29(6):513-22. PubMed ID: 20881863
[TBL] [Abstract][Full Text] [Related]
6. The p16 (CDKN2a/INK4a) tumor-suppressor gene in head and neck squamous cell carcinoma: a promoter methylation and protein expression study in 100 cases.
Ai L; Stephenson KK; Ling W; Zuo C; Mukunyadzi P; Suen JY; Hanna E; Fan CY
Mod Pathol; 2003 Sep; 16(9):944-50. PubMed ID: 13679459
[TBL] [Abstract][Full Text] [Related]
7. High prevalence of p16 staining in malignant tumors.
De Wispelaere N; Rico SD; Bauer M; Luebke AM; Kluth M; Büscheck F; Hube-Magg C; Höflmayer D; Gorbokon N; Weidemann S; Möller K; Fraune C; Bernreuther C; Simon R; Kähler C; Menz A; Hinsch A; Jacobsen F; Lebok P; Clauditz T; Sauter G; Uhlig R; Wilczak W; Steurer S; Burandt E; Krech R; Dum D; Krech T; Marx A; Minner S
PLoS One; 2022; 17(7):e0262877. PubMed ID: 35862385
[TBL] [Abstract][Full Text] [Related]
8. Prognostic implications of genotyping and p16 immunostaining in HPV-positive tumors of the uterine cervix.
Nicolás I; Saco A; Barnadas E; Marimon L; Rakislova N; Fusté P; Rovirosa A; Gaba L; Buñesch L; Gil-Ibañez B; Pahisa J; Díaz-Feijoo B; Torne A; Ordi J; Del Pino M
Mod Pathol; 2020 Jan; 33(1):128-137. PubMed ID: 31492932
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical Study of p16INK4A, MIB-1 and CK17 in Pre-neoplastic and Neoplastic Epithelial Lesions of Cervix.
Sahu PD; Khandeparkar SGSKS; Joshi AR; Kulkarni MM; Gogate BP; Newadkar ND; Shinde PA; Battin SS
Gulf J Oncolog; 2022 Sep; 1(40):29-37. PubMed ID: 36448068
[TBL] [Abstract][Full Text] [Related]
10. [Significance of p16/Ki-67 double immunocytochemical staining in cervical cytology ASCUS, LSIL, and ASC-H].
Wu Y; Zhao J; Hu J; Wu XW; Zhu LR
Zhonghua Fu Chan Ke Za Zhi; 2017 Nov; 52(11):734-739. PubMed ID: 29179267
[No Abstract] [Full Text] [Related]
11. Association of P16, Ki-67, and CD44 expression in high-grade squamous intraepithelial neoplasia and squamous cell carcinoma of the cervix.
Mehdi HK; Raju K; Sheela SR
J Cancer Res Ther; 2023 Apr; 19(Supplement):S260-S267. PubMed ID: 37148002
[TBL] [Abstract][Full Text] [Related]
12. Research on expression and importance of p53, p16 and VEGF-C in cervical cancer.
Cai S; Han K
J Gynecol Obstet Biol Reprod (Paris); 2015 Sep; 44(7):639-45. PubMed ID: 25443468
[TBL] [Abstract][Full Text] [Related]
13. The expression of p16 and galectin-3 in cervical intraepithelial neoplasia (CIN) and squamous cell carcinoma (SCC) uterine cervix.
Kumar R; Mandal S; Arora P; Mala YM; Khurana N
J Obstet Gynaecol; 2021 Jul; 41(5):785-790. PubMed ID: 33073644
[TBL] [Abstract][Full Text] [Related]
14. Introduction of p16
Sarwath H; Bansal D; Husain NE; Mohamed M; Sultan AA; Bedri S
Infect Agent Cancer; 2017; 12():50. PubMed ID: 29021820
[TBL] [Abstract][Full Text] [Related]
15. [Clinical value of p16
Song FB; Du H; Xiao AM; Wang C; Huang X; Yan PS; Liu ZH; Qu XF; Belinson JEROMEL; Wu RF
Zhonghua Fu Chan Ke Za Zhi; 2020 Nov; 55(11):784-790. PubMed ID: 33228350
[No Abstract] [Full Text] [Related]
16. Efficiency of immunohistochemical p16 expression and HPV typing in cervical squamous intraepithelial lesion grading and review of the p16 literature.
Yildiz IZ; Usubütün A; Firat P; Ayhan A; Küçükali T
Pathol Res Pract; 2007; 203(6):445-9. PubMed ID: 17543474
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical overexpression of p16 protein associated with cervical cancer in Thailand.
Jedpiyawongse A; Homcha-em P; Karalak A; Srivatanakul P
Asian Pac J Cancer Prev; 2008; 9(4):625-30. PubMed ID: 19256750
[TBL] [Abstract][Full Text] [Related]
18. Grading of atypia in genital skin lesions: routine microscopic evaluation and use of p16 immunostaining.
Ezaldein H; Lott JP; McNiff JM; Hui P; Buza N; Ko CJ
J Cutan Pathol; 2015 Aug; 42(8):519-26. PubMed ID: 25951050
[TBL] [Abstract][Full Text] [Related]
19. An evaluation of the diagnostic and prognostic significance of p16(INK4a) /p21(WAF1/Cip1) immunostaining in squamous intraepithelial lesions of the uterine cervix using liquid-based cytology specimens.
Ishida K; Araki A; Kobayashi M; Taniyama K; Nabika T; Nagasaki M
Diagn Cytopathol; 2014 Feb; 42(2):125-33. PubMed ID: 23754829
[TBL] [Abstract][Full Text] [Related]
20. Dual immunostaining of cervical cytology specimens with atypical squamous cells for p16/Ki-67 does not exclude the existence of a high-grade squamous intraepithelial lesion.
Koo YJ; Hahn HS; Lee IH; Lim KT; Lee KH; Kim HS; Kim TJ; Chun YK; Kim HS; Hong SR
Virchows Arch; 2013 Nov; 463(5):689-96. PubMed ID: 24081504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
